Abstract
Disintegrins represent a class of low molecular weight, Arg-Gly-Asp(RGD)/Lys-Gly-Asp(KGD)-containing, cysteine-rich polypeptides derived from venoms of various viper snakes. They bind to various integrins (e.g. αIIbβ3, αvβ3, α5β1 and others) expressed on cell membrane surface, with various degrees of affinity and specificity. Disintegrins were originally discovered as antiplatelet agents by acting as platelet membrane αIIbβ3 antagonists. However, they also have been found to bind αvβ3, α5β1 or α4β1 expressed on endothelial cells, fibroblasts, phagocytes, and tumor cells, thus affecting cell-matrix and cell-cell interaction. The homologous molecular structure among disintegrin, snake venom metalloproteinase (SVMP), and ADAM (a disintegrin and metalloproteinase) reveals their evolutionary relationship. Based on the structure-activity relationship of these molecules and integrins, the potential applications of these disintegrins and their derivatives are briefly discussed in field of arterial thrombosis, cell adhesion, cell migration, angiogenesis, inflammation, and tumor metastasis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adler, M., Lazarus, R.A., Dennis, M.S., Wagner, G.., 1991. Solution structure of kistrin, a potent platelet aggregation inhibitor and GPIIb/IIIa antagonist. Science 253, 445–448.
Au, L.C., Chou, J.S., Chang, K.J., Teh, G.W., Lin, S.B., 1993. Nucleotide sequence of a full-length cDNA encoding a common precursor of platelet aggregation inhibitor and hemorrhagic protein from Calloselasma rhodostoma venom. Biochim. Biophys. Acta 1173, 243–245.
Au, L.C., Huang, Y.B., Huang, T.F., The, G.W., Lin, H.H., Choo, K.B., 1991. A common precursor for a putative hemorrhagic protein and rhodostomin, a platelet aggregation inhibitor of the venom of Calloselasma rhodostoma: molecular cloning and sequence analysis. Biochem. Biophys. Res. Commun. 181, 585–593.
Beer, J.H., Springer, K.T., Coller, B.S., 1992. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood 79, 117–128.
Brooks, P.C., Clark, R.A.F., Cheresh, D.A., 1994a. Requirement of vascular integrin alpha-v/beta-3 for angiogenesis. Science 264, 569–571.
Brooks, P.C., Montgomery, A.M., Rosenfeld, M., Reisfeld, R.A., Hu, T., Klier, G., 1994b. Integrin alpha-v/beta-3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164.
Beviglia, L., Stewart, G.J., Niewiarowski, S., 1995. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol. Res. 7, 7–20.
Calvete, J.J., Moreno-Murciano, M.P., Theakston, R.D., Kisiel, D.G., Marcinkiewicz, C., 2003. Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem. J. 372, 725–734.
Chang, M.C., Jeng, J.H., Cheong, T.C., Huang, T.F., 1995b. The morphologic change of endothelial cells by ancrod-generated fibrin is triggered by alpha v beta 3 integrin binding and the subsequent activation of a G-protein coupled phospholipase C. Biochim. Biophys. Acta 1269, 115–121.
Chang, M.C., Wang, B.R., Huang, T.F., 1995a. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides. Thromb. Haemost. 74, 764–769.
Chiang, H.S., Peng, H.C., Huang, T.F., 1994a. Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion. Biochim. Biophys. Acta 1224, 506–516.
Chiang, H.S., Swain, M.W., Huang, T.F., 1994b. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br. J. Haematol. 87, 325–331.
Chiang, H.S., Yang, R.S., Huang, T.F., 1996. Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin. Br. J. Cancer 73, 902–908.
Coller, B.S., 1990. Platelets and thrombolytic therapy. N. Engl. J. Med., 322, 33–42
Cook, J.J., Huang, T.F., Rucinski, B., Strzyzewski, M., Tuma, R.F., Williams, J.A., Niewiarowski, S., 1989. Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. Am. J. Physiol. 256, H1038–H1043.
Fisher, J.E., Caulfield, M.P., Sato, M., Quartuccio, H.A., Gould, R.J., Garsky, V.M., Rodan, G.A., Rosenblatt, M., 1993. Inhibition of osteoclastic bone resorption in vivo by echistatin, an “arginyl-glycyl-aspartyl” (RGD)-containing protein. Endocrinology 132, 1411–1413.
Folkman, J., 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27–31
Folkman, J., Shing, Y., 1992. Angiogenesis. J. Biol. Chem. 267, 10931–10934
Frank, J.D., Gould, R.J., Schaffer, L.W., Davidson, J.T., Gibson, R.E., Patrick, D.H., Vonderfecht, S.L., Cartwright, M.E., 1992. Immunocytochemical localization of platelets in baboon hepatic sinusoids using monoclonal mouse anti-human platelet glycoprotein IIIa following induction of thrombocytopenia. Histochemistry 97, 355–360.
Frelinger, A.L., Du, X.P., Plow, E.F., 1991. Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J. Biol. Chem. 266, 17106–17111.
Fu, W.M., Chang, T.K., Sun, W.Z., Ling, Q.D., Peng, H.C., Liou, H.C., Lu, D.Y., Huang, T.F., 2004. Inhibition of neuropathic pain by a potent disintegrin – triflavin. Neurosci. Lett. 368, 263–268.
Gan, Z.R., Gould, R.J., Jacobs, J.W., Friedman, P.A., Polokoff, M.A., 1988. Echistatin: a potent platelet aggregation inhibitor from the venom of the viper, Echis carinatus. J. Biol. Chem. 263, 19827–19832.
Gartner, T.K., Bennett, J.S., 1985. The tetrapeptide analogue of cell attachment site of fibrinogen inhibits platelet aggregation and fibrinogen binding to activated platelets. J. Biol. Chem. 269, 11891–11894.
George, J.N., Caen, J.P., Nurden, A.T., 1990. Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood 75, 1383–1395.
Ginsberg, M.H., Loftus, J.C., Plow, E.F., 1988. Cytoadhsion integrins and platelets. Thromb. Haemost. 59, 1–6.
Gould, R.J., Polokoff, M.A., Friedman, P.A., Huang, T.F., Holt, J.C., Cook, J.J., Niewiarowski, S., 1990. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 195, 168–171.
Hammes, H.P., Brownlee, M., Jonczyk, A., Sutter, A., Preissner, K.T., 1996. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2, 529–533.
Hite, L.A., Shannon, J.D., Bjarnason, J.B., Fox, J.W., 1992. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal, zymogen, and disintegrin-like structures. Biochemistry 31, 6203–6211.
Hsu, C.C., Huang, T.F., 2009. A disintegrin, rhodostomin, inhibits activity of LPS-treated monocytes via αvβ3 integrin. J. Thromb. Haemost. 7, S2, Abstract PP-MO-879.
Huang, T.F., 1998. What have snakes taught us about integrins? Cell. Mol. Life Sci. 54, 527–540.
Huang, T.F., Holt, J.C., Kirby, E.P., Niewiarowski, S., 1989. Trigramin: primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb/IIIa complex on human platelets. Biochemistry 28, 661–666.
Huang, T.F., Holt, J.C., Lukasiewicz, H., Niewiarowski, S., 1987b. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex. J. Biol. Chem. 262, 16157–16163.
Huang, T.F., Liu, C.Z., Ouyang, C., Teng, C.M., 1991a. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptides, as fibrinogen receptor antagonist. Biochem. Pharmacol. 42, 1209–1219.
Huang, T.F., Ouyang, C., 1984. Action mechanism of the potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Thromb. Res. 33, 125–138.
Huang, T.F., Sheu, J.R., Teng, C.M., Chen, S.W., Liu, C.S., 1991b. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex. J. Biochem. (Tokyo) 109, 328–334.
Huang, T.F., Wang, W.J., Teng, C.M., Ouyang, C., 1991c. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom. Biochim. Biophys. Acta. 1074, 144–150.
Huang, T.F., Wu, Y.J., Ouyang, C., 1987a. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom. Biochim. Biophys. Acta 925, 248–257.
Hynes, R.O., 1992. Integrins: versatility, modulation and signaling in cell adhesion. Cell 69, 11–25.
Jia, L.G., Wang, X.M., Shannon, J.D., Bjarnason, J.B., Fox, J.W., 1997. Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J. Biol. Chem. 272, 13094–13102.
Jin, H., Varner, J., 2004. Integrins: roles in cancer development and as treatment targets. Br. J. Cancer 90, 561–565.
Kini, R.M., Evans, H.J., 1992. Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30, 265–293.
Knudsen, K.A., Tuszynski, G.P., Huang, T.F., Niewiarowski, S., 1988. Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Exp. Cell Res. 179, 42–49.
Lin, Y.T., Tang, C.H., Chuang, W.J., Wang, S.M., Huang, T.F., Fu, W.M., 2005. Inhibition of adipogenesis by RGD-dependent disintegrin. Biochem. Pharmacol. 70, 1469–1478.
Liu, C.Z., Hur, B.T., Huang, T.F., 1996. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluoresein isothiocyanate-conjugated crotavirin, a member of disintegrins. Thromb. Haemostas. 76, 585–591.
Liu, C.Z., Wang, Y.W., Shen, M.C., Huang, T.F., 1994. Analysis of human platelet glycoprotein IIb/IIIa by fluorescein isothiocyanate-conjugated disintegrins with flow cytometry. Thromb. Haemostas. 72, 919–925.
Lu, Q., Clemetson, J.M., Clemetson, K.J., 2005. Snake venoms and hemostasis. J. Thromb. Haemost. 3, 1791–1799.
Marcinkiewicz, C., Calvete, J.J., Marcinkiewicz, M.M., Raida, M., Vijay-Kumar, S., Huang, Z., Lobb, R.R., Niewiarowski, S., 1999. EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner. J. Biol. Chem. 274, 12468–12473.
Menter, D.G., Steinert, B.W., Sloane, B.F., Gundlach, N., O’Gara, C.Y., Marnett, L.J., Diglio, C., Walz, D., Taylor, J.D., Honn, K.V., 1987. Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix. Cancer Res. 47, 6751–6762.
Mould, A.P., Symonds, E.J., Buckley, P.A., Grossmann, J.G., McEwan, P.A., Barton, S.J., Askari, J.A., Craig, S.E., Bella, J., Humphries, M.J., 2003. Structure of an integrin-ligand complex deduced from solution x-ray scattering and site-directed mutagenesis. J. Biol. Chem. 278, 39993–39999.
Musial, J., Niewiarowski, S., Rucinski, B., Stewart, G.J., Cook, J.J., Williams, J.A., Edmunds, L.H., Jr., 1990. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation 82, 261–273.
Nieuwenhuis, H.K., Akkerman, J.W., Houdijk, W.P., Sixma, J.J., 1985. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318, 470–472.
Ouyang, C., Huang, T.F., 1983. Potent platelet aggregation inhibitor from Trimeresurus gramineus snake venom. Biochim. Biophys. Acta 757, 332–341.
Ouyang, C., Teng, C.M., Huang, T.F., 1992. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30, 945–966.
Ouyang, C., Yeh, H.I., Huang, T.F., 1983. A potent platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon 21, 797–804.
Paine, M.J., Desmond, H.P., Theakston, R.D., Crampton, J.M., 1992. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. Insights into the disintegrin gene family. J. Biol. Chem. 267, 22869–22876.
Rote, W.E., Mu, D.X., Roncinske, R.A., Frelinger, A.L., 3rd, Lucchesi, B.R., 1993. Prevention of experimental carotid artery thrombosis by applaggin. J. Pharmacol. Exp. Ther. 267, 809–814.
Rucinski, B., Niewiarowski, S., Holt, J.C., Soszka, T., Knudsen, K.A., 1990. Batroxostatin, an Arg-Gly-Asp containing peptide from Bothrops atrox, a potent inhibitor of platelet aggregation and cell interaction with fibronectin. Biochem. Biophys. Acta 1054, 257–262.
Sato, M., Sardana, M.K., Grasser, W.A., Garsky, V.M., Murray, J.M., Gould, R.J., 1990. Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111, 1713–1723.
Savage, B., Marzec, U.M., Chao, B.H., Harker, L.A., Maragnone, J.M., Ruggeri, Z.M., 1990. Binding of the snake venom-derived proteins applagin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb/IIIa complex inhibits receptor function. J. Biol. Chem. 265, 11766–11772.
Scarborough, R.M., Naughton, M.A., Teng, W., Rose, J.W., Phillips, D.R., Nannizzi, L., Arfsten, A., Campbell, A.M., Charo, I.F., 1993a. Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J. Biol. Chem. 268, 1066–1073.
Scarborough, R.M., Rose, J.W., Hsu, M.A., Phillips, D.R., Fried, V.A., Campbell, A.M. Nannizzi, L., Charo, I.F., 1991. Barbourin. A GPIIb-IIIa-specific integrin antagonists from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266, 9359–9362.
Scarborough, R.M., Rose, J.W., Naughton, M.A., Philips, D.R., Nannizzi, L., Arfsten, A., Campbell, A.M., Charo, I.F., 1993b. Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J. Biol. Chem. 268, 1058–1065.
Sheu, J.R., Lin, C.H., Chuang, J.L., Teng, C.M., Huang, T.F., 1992a. Triflavin, an Arg-Gly-Asp-containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line. Thromb. Res. 66, 679–691.
Sheu, J.R., Lin, C.H., Chung, J.L., Teng, C.M., Huang, T.F., 1992b. Triflavin, an Arg-Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization. Jpn. J. Cancer Res. 83, 885–893.
Sheu, J.R., Lin, C.H., Huang, T.F., 1994a. Triflavin, an antiplatelet peptide inhibits tumor cell-extracellular matrix adhesion via an RGD-dependent mechanism. J. Lab. Clin. Med. 123, 256–263.
Sheu, J.R., Lin, C.H., Peng, H.C., Huang, T.F., 1994b. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism. Peptides 15, 1391–1398.
Sheu, J.R., Lin, C.H., Peng, H.C., Huang, T.F., 1996. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proc. Soc. Exp. Biol. Med. 213, 71–79.
Sheu, J.R., Teng, C.M., Huang, T.F., 1992c. Triflavin, an RGD-containing antiplatelet peptide, binds to GpIIIa of ADP-stimulated platelets. Biochem. Biophys. Res. Commun. 189, 1236–1342.
Sheu, J.R., Yen, M.H., Hung, W.C., Lee, Y.M., Su, C.H., Huang, T.F., 1997. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta. Arterioscler. Thromb. Vasc. Biol. 17, 3461–3468.
Suehiro, K, Smith, J.W., Plow, E.F., 1996. The ligand recognition specificity of ß3 integrins. J. Biol. Chem. 271, 10365–10371
Swaim, M.W., Chiang, H.S., Huang, T.F., 1996. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin. Eur. J. Cancer 32A, 715–721.
Swenson, S., Ramu, S., Markland, F.S., 2007. Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr. Pharm. Des. 13, 2860–3871.
Takeda, S., 2009. Three-dimensional domain architecture of the ADAM family proteinases. Semin. Cell Dev. Biol. 20, 146–152.
Takeya, H., Oda, K., Miyata, J., Omori-Satoh, T., Iwanaga, S., 1990. The complete amino acid sequence of high molecular mass haemorrhagic protein HR1B isolated from the venom Trimeresurus flavoviridis. J. Biol. Chem. 265, 16068–16073.
Tcheng, J.E., Harrington, R.A., Kottke-Marchant, K., Kleiman, N.S., Ellis, S.G., Kereiakes, D.J., Mick, M.J., Navetta, F.I., Smith, J.E., Worley, S.J., Miller, J.A., Joseph, D.M., Sigmon, K.N., Kitt, M.M., du Mée, C.P., Califf, R.M., Topol, E.J., 1995. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators. Circulation 91, 2151–2157.
Teng, C.M., Huang, T.F., 1991. Snake venom constituents that affect platelet function. Platelets 2, 77–87.
The EPIC investigations. 1994. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med. 330, 956–961.
Tsai, T.J., Sheu, J.R., Chen, Y.M., Yen, C.J., Chen, C.F., Huang, T.F., 1995. Disintegrin modulates rat glomerular mesangial cell behavior. Nephron 70, 83–90.
Tseng, Y.L., Peng, H.C., Huang, T.F., 2004. Rhodostomin, a disintegrin, inhibits adhesion of neutrophils to fibrinogen and attenuates superoxide production. J. Biomed. Sci. 11, 683–691.
Watson, S.P, Auger, J.M., McCarty, O.J., Pearce, A.C., 2005. GPVI and integrin alphaIIb beta3 signaling in platelets. J. Thromb. Haemost. 3, 1752–1762.
Weller, T., Alig, L., Muller, M.H., Kouns, W.C., Steiner, B., 1994. Fibrinogen receptor antagonists - a novel class of promising antithrombotics. Drugs Future 19, 461–476.
Wesolowski, G., Duong, L.T., Lakkakorpi, P.T., Nagy, R.M., Tezuka, K., Tanaka, H., Rodan, G.A., Rodan, S.B., 1995. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp. Cell Res. 219, 679–686.
Wu, W.B., Peng, H.C., Huang, T.F., 2003. Disintegrin causes proteolysis of beta-catenin and apoptosis of endothelial cells. Involvement of cell-cell and cell-ECM interactions in regulating cell viability. Exp. Cell Res. 286, 115–127.
Yang, R.S., Tang, C.H., Chuang, W.J., Huang, T.H., Peng, H.C., Huang, T.F., Fu, W.M., 2005. Inhibition of tumor formation by snake venom disintegrin. Toxicon 45, 661–669.
Yasuda, T., Gold, H.K., Leinbach, R.C., Yaoita, H., Fallon, J.T., Guerrero, L., Napier, M.A., Bunting, S., Collen, D., 1991. Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation 83, 1038–1047.
Yeh, C.H., Peng, H.C., Huang, T.F., 1998. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 92, 3268–3276.
Yeh, C.H., Peng, H.C., Yang, R.S., Huang, T.F., 2001. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective αvβ3 blockade of endothelial cells. Mol. Pharmacol. 59, 1333–1342.
Acknowledgements
I would like to thank my Ph.D. thesis advisor, Dr. C. Ouyang, who encouraged me to stick on the topic entitled “Platelet inhibitory components in Trimeresurus gramineus venom” from which the first disintegrin Trigramin was discovered. Next, I also thank my partners Drs. S. Niewiarowski and Dr. J.C. Holt, Thrombosis Research Center, Temple University School of Medicine, who helped me to elucidate the primary sequence of the first naturally-occurring RGD-containing disintegrin, its primary target of platelet αIIbβ3,and its in vivo antithrombotic activity. Thanks to my graduate students and assistants for the devoted pursuit of the mysterious biology of snake venom. Finally, I appreciate the long-term financial support from National Science Council of Taiwan.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Huang, TF. (2010). The Discovery of Disintegrins. In: Kini, R., Clemetson, K., Markland, F., McLane, M., Morita, T. (eds) Toxins and Hemostasis. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9295-3_17
Download citation
DOI: https://doi.org/10.1007/978-90-481-9295-3_17
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9294-6
Online ISBN: 978-90-481-9295-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)